Pregnancy Registry in Mali

NCT ID: NCT06468319

Last Updated: 2025-09-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

9500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-08-05

Study Completion Date

2030-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This registry will assess pregnancy outcomes through demographic surveillance and prospective data collection at a health facility in Kalifabougou, Mali.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This pregnancy registry will gather background data on pregnancy rates and outcomes as well as infant health data to inform future implementation of clinical trials testing monoclonal antibodies (mAbs) to prevent malaria in pregnancy.

In the first part of the study (Community Census Cohort), women of child-bearing age (WOCBA) in the community will be identified and followed for up to 3 years to detect pregnancy at all stages. Upon detection of pregnancy, these women may then transition to participation in the Health Facility Cohort.

In the second part of the study (Health Facility Cohort), data will be prospectively collected from pregnant women presenting at the health facility for antenatal care (ANC) visits or referred in from the Community Census Cohort. The pregnant women will be followed through pregnancy outcome and until 12 months postpartum, and their infant(s) will be followed until 12 months of age.

The study team will collect baseline information in a systematic manner on early pregnancy events, pregnancy and postpartum complications and outcomes, utilization of existing malaria prevention tools, malaria infections and clinical disease, birth outcomes, and follow-up of subsequent offspring.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Malaria Pregnancy Related

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Community Census Cohort

Women of child-bearing aged (WOCBA) identified within the community.

No interventions assigned to this group

Health Facility Cohort

Pregnant women presenting at the health facility for antenatal care or referred in from the Community Consensus Cohort.

No interventions assigned to this group

Offspring from Health Facility Cohort

Children born to women in the health facility cohort.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Community Census Cohort:

1. Females of childbearing potential or pregnant females.
2. Aged 15 to 49 years.
3. Able to provide verbal individual informed consent.

Health Facility Cohort:

1. Pregnant females 15 to 49 years and their subsequent offspring.
2. Resides in or in the health catchment area of Kalifabougou and willing to return to the health center for Antenatal Care (ANC) visits.
3. Able to provide written individual informed consent for herself and her future offspring(s).

Exclusion Criteria

Community Census Cohort:

1. Temporary residence in the study area.
2. Other condition(s) that, in the opinion of the investigator, would jeopardize the safety or rights of an individual participating in the study, interfere with the evaluation of the study objectives, or render the participant unable to comply with the protocol.

Health Facility Cohort:

1. Temporary residence in the study area.
2. Other condition(s) that, in the opinion of the investigator, would jeopardize the safety or rights of an individual participating in the study, interfere with the evaluation of the study objectives, or render the participant unable to comply with the protocol.
Minimum Eligible Age

15 Years

Maximum Eligible Age

49 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institutes of Health (NIH)

NIH

Sponsor Role collaborator

University of Washington

OTHER

Sponsor Role collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kassoum Kayentao, MD, MPH, PhD

Role: PRINCIPAL_INVESTIGATOR

Faculté de Médecine Pharmacie d'Odontostomatologie (FMOS)

Peter Crompton, MD, MPH

Role: PRINCIPAL_INVESTIGATOR

National Institutes of Health (NIH)

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Kalifabougou MRTC Clinic

Kalifabougou, Koulikoro, Mali

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Mali

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Kassoum Kayentao, MD, MPH, PhD

Role: CONTACT

+223 7646 0173

Boubacar Traore, PharmD, PhD

Role: CONTACT

+223 20 22 14 17

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Kassoum Kayentao, MD, MPH, PhD

Role: primary

+223 7646 0173

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2024/84/CE/USTTB

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Zambian Preterm Birth Prevention Study
NCT02738892 ACTIVE_NOT_RECRUITING
Pompe Pregnancy Sub-Registry
NCT00567073 RECRUITING
Maternal Newborn Health Registry
NCT01073475 RECRUITING
Dengvaxia US Pregnancy Registry
NCT04486638 RECRUITING